Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v2-FR
Language French French
Date Updated 2021-01-21 2020-11-12
Drug Identification Number 00870226 00870226
Brand name RATIO-DOCUSATE SODIUM RATIO-DOCUSATE SODIUM
Common or Proper name DOCUSATE SOD 20MG/5ML SYRUP DOCUSATE SOD 20MG/5ML SYRUP
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients DOCUSATE SODIUM DOCUSATE SODIUM
Strength(s) 20MG 20MG
Dosage form(s) SYRUP SYRUP
Route of administration ORAL ORAL ORAL ORAL
Packaging size 500ml 500ml
ATC code A06AA A06AA
ATC description DRUGS FOR CONSTIPATION DRUGS FOR CONSTIPATION
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-11-11 2020-11-11
Estimated end date 2021-01-31 2020-12-31
Actual end date 2021-01-20
Shortage status Resolved Actual shortage
Company comments
Health Canada comments